why choose us

300×250 Ad Slot

Research Article: Treatment of Diabetic Macular Edema or Macular Edema Following Retinal Vein Occlusion Based on Repeated Injection of the Dexamethasone Intravitreal Implant: A Retrospective Real-World Analysis

Date Published: 2023-10-24

Introduction:
The dexamethasone intravitreal implant (DEX) is a biodegradable, polymer-based drug delivery system designed to provide sustained release of the potent corticosteroid, dexamethasone, within the vitreous cavity for up to months. In selected patients with macular edema, it can be used to reduce inflammation by inhibiting fibrin deposition, capillary leakage and phagocytic migration, and by inhibiting the expression of vascular endothelial growth factor (VEGF), a promoter of vascular permeability. ,

Read more

300×250 Ad Slot